Star Equity Holdings to Release Second Quarter 2024 Financial Results on August 13th
OLD GREENWICH, Conn., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP), (“Star Equity” or the...
PR News
Star Equity Holdings to Release Second Quarter 2024 Financial Results on August 13th
OLD GREENWICH, Conn., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP), (“Star Equity” or the...
Stratasys Announces Move to Minnetonka Campus, Enhancing Innovation and Work Environment
Contacts Media contacts: Chris Reese, Stratasys Corporate, Americas Region, EMEA Region Public Relations, +1 651 357 0877 Erik Snider, Stratasys...
Sidus Space Founder and CEO Carol Craig Named to Forbes 50 Over 50 List
Contacts Investor Relations investorrelations@sidusspace.com Media Inquiries press@sidusspace.com Sidus Space (NASDAQ: SIDU) (the “Company” or “Sidus”), a provider of end-to-end precision...
The Shyft Group to Participate in the Raymond James Industrial and Energy Showcase
NOVI, Mich., Aug. 8, 2024 /PRNewswire/ -- The Shyft Group, Inc. (NASDAQ: SHYF) ("Shyft" or the "Company"), the North American...
Sharecare announces second quarter 2024 financial results and operational highlights
ATLANTA, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their...
Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024
SALT LAKE CITY, Aug. 8, 2024 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and...
Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference
REDWOOD CITY, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a...
Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates
AUSTIN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on a novel...
Leading online travel company Priceline and Sabre sign expanded, multi-year distribution agreement
The new relationship will focus on driving innovation and delivering superior content to travelers SOUTHLAKE, Texas, Aug. 8, 2024 /PRNewswire/...
Rumble’s Founder and CEO Chris Pavlovski to Hold a Post-Earnings Live Stream with Matt Kohrs via Rumble Studio
LONGBOAT KEY, FL, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Rumble Inc. (NASDAQ: RUM), the video-sharing platform and cloud services provider,...
Construction Partners, Inc. Announces Fiscal 2024 Third Quarter Results
Revenue Up 22.7% Compared to Q3 FY23 Net Income Up 42.4% Compared to Q3 FY23 Adjusted EBITDA Up 30.5% Compared...
Avidity Biosciences Announces Positive AOC 1044 Data Demonstrated Significant Increase of 25% in Dystrophin Production and Reduction of Creatine Kinase Levels to Near Normal in People Living with Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping in
Delpacibart zotadirsen (AOC 1044) delivered unsurpassed muscle concentrations of PMO of 200 nM after three doses of 5 mg/kg Statistically...
Rallybio Reports Second Quarter 2024 Financial Results and Provides Business Updates
– On Track to Initiate RLYB212 Phase 2 Dose Confirmation Trial in Pregnant Women at Higher Risk of FNAIT in...
Replimune Reports Fiscal First Quarter 2025 Financial Results and Provides Corporate Update
WOBURN, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the...
red violet to Participate in the Midwest IDEAS Investor Conference
BOCA RATON, Fla., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions...
U.S. Housing Market Nears $50 Trillion in Value as Number of Trillion-Dollar Metros Doubles
Redfin reports there are now eight metros, up from four a year ago, where the total value of homes topped...
RAPT Therapeutics Reports Second Quarter 2024 Financial Results
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company...
Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results
Quoin Broadens Product Portfolio through Research Agreement with University College Cork, IrelandCompany Expands On-going Clinical Trials in Netherton Syndrome to...
Plus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024
AUSTIN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted...
ParaZero Technologies Ltd. (NASDAQ: PRZO) Announces Receipt of Extension to Meet the Nasdaq’s Minimum Bid Price Requirement
Tel Aviv, Israel, Aug. 09, 2024 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the "Company” or “ParaZero”), an aerospace...
Priority Technology Holdings, Inc. Announces Second Quarter Financial Results
Strong Second Quarter Growth Driven by Performance Across Unified Commerce Platform Contacts Priority Investor Inquiries: Chris Kettmann Chris.Kettmann@dgagroup.com (773) 497-7575...
ProKidney Reports Business Updates and Second Quarter 2024 Financial Results
WINSTON-SALEM, N.C., Aug. 09, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage...
Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates
CAMBRIDGE, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a...
Perficient Reports Second Quarter 2024 Results
Contacts Bill Davis, Perficient, 314-529-3555 bill.davis@perficient.com Perficient, Inc. (Nasdaq: PRFT) (“Perficient”), the leading global digital consultancy transforming the world’s largest...
PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial
PRINCETON, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery...
Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System
Company’s proprietary system used in study for patients with atrial fibrillation Cardiac Surgery System enrolled in the FDA’s Total Product...
Palomar Holdings, Inc. Announces Pricing of Public Offering of Common Stock
LA JOLLA, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Palomar Holdings, Inc. (“Palomar” or the “Company”) today announced the pricing...
Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
FLORHAM PARK, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing...
Pagaya and Castlelake Announce Forward Flow Agreement to Purchase up to $1 Billion of Consumer Loans Originated on the Pagaya Network
Transaction diversifies Pagaya’s funding sources and drives capital efficiency, in line with the Company’s financial strategy Contacts Pagaya Investors &...
Perma-Fix Reports Financial Results and Provides Business Update for the Second Quarter of 2024
ATLANTA, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced financial results and...
PepGen Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
– CONNECT1-EDO51 clinical trial data from low-dose cohort were reported in July. PGN-EDO51 at 5 mg/kg was well tolerated, achieved...
Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing Event
Event held at Fort Worth Fire Department in partnership with Front Line Mobile Health NEW YORK, Aug. 8, 2024 /PRNewswire/...
Palisade Bio Selects Dose for Upcoming Phase 1 Clinical Study of PALI-2108 for Ulcerative Colitis
– Phase 1 human clinical study of PALI-2108 for the treatment of Ulcerative Colitis (UC) on track to commence before...
Oxford Lane Capital Corp. Provides July Net Asset Value Update
GREENWICH, Conn., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO)...
Oxford Lane Capital Corp. Provides July Net Asset Value Update
GREENWICH, Conn., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO)...
Oxford Lane Capital Corp. Provides July Net Asset Value Update
GREENWICH, Conn., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO)...
Oxford Lane Capital Corp. Provides July Net Asset Value Update
GREENWICH, Conn., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO)...
Oxford Lane Capital Corp. Provides July Net Asset Value Update
GREENWICH, Conn., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO)...
Oxford Lane Capital Corp. Provides July Net Asset Value Update
GREENWICH, Conn., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO)...